Curated News
By: NewsRamp Editorial Staff
September 22, 2026
ROTH Hosts 5th Annual Healthcare Conference in NYC
TLDR
- Gain exclusive access to 30 public healthcare companies and institutional investors at Roth Capital Partners' invitation-only conference on Sept. 29, 2026.
- Roth Capital Partners will host its 5th Annual Healthcare Opportunities Conference on Sept. 29, 2026, featuring one-on-one meetings and discussions on neuroscience, drug pricing, and regulatory issues.
- Roth Capital Partners' healthcare conference fosters collaboration among industry leaders to advance biotechnology, diagnostics, and medical technology for better patient outcomes.
- Roth Capital Partners' 5th Annual Healthcare Opportunities Conference will be held on Sept. 29, 2026, at the Metropolitan Club in New York City, featuring over 30 public healthcare companies.
Impact - Why it Matters
The ROTH Healthcare Opportunities Conference serves as a vital nexus for investors and healthcare innovators, particularly as the biotechnology sector faces regulatory and capital challenges. By facilitating direct access to C-suite executives from over 30 public companies, the event empowers institutional investors to make informed decisions on emerging therapies and technologies. The discussions on drug pricing, regulatory uncertainty, and cutting-edge areas like MRD monitoring in solid tumors highlight critical issues that shape investment strategies and ultimately influence patient access to novel treatments. With ROTH's extensive track record of over 600 transactions worth $25 billion since 2010, the conference underscores the bank's role in driving growth and innovation in healthcare. This gathering not only fosters deal-making but also provides a barometer for the industry's health and future direction.
Summary
Roth Capital Partners is set to host its 5th Annual Healthcare Opportunities Conference on September 29, 2026, at the Metropolitan Club in New York City. The invitation-only event will bring together C-suite executives from more than 30 public healthcare companies and leading institutional investors for a day of strategic engagement. The conference will feature one-on-one and small-group meetings with companies representing biotechnology, life science tools and diagnostics, and medical technology, providing a unique platform for direct dialogue between investors and industry leaders.
The event will also include discussions on critical topics such as neuroscience, drug pricing and coverage, regulatory uncertainty, capital constraints in biotechnology, and minimal residual disease (MRD) monitoring in solid tumors. Hosting the conference are ROTH’s senior healthcare research analysts Jonathan Aschoff, Ph.D., Max Masucci, Boobalan Pachaiyappan, Ph.D., and Adam Walsh, MD. Since 2010, ROTH has been involved in more than 600 transactions for healthcare clients, representing over $25 billion in total transaction value, underscoring its deep expertise in the sector. To view the full calendar of events, visit https://ibn.fm/vDTjP.
ROTH is a relationship-driven investment bank focused on serving growth companies and their investors, offering a full-service platform that includes capital raising, high-impact equity research, macroeconomics, sales and trading, technical insights, derivatives strategies, M&A advisory, and corporate access. Headquartered in Newport Beach, California, ROTH is a privately held, employee-owned firm with offices across the U.S. For more information, visit www.roth.com. The conference is supported by InvestorWire, a specialized communications platform under the Dynamic Brand Portfolio @ IBN, which provides wire-grade press release syndication, editorial syndication to 5,000+ outlets, press release enhancement, social media distribution, and corporate communications solutions.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, ROTH Hosts 5th Annual Healthcare Conference in NYC
